D.22 EQM MEASURES.pdf

PDF 248 KB Posted

Attached to
Q201--Kay County OK CBOC Services
Solicitation number
36C25922R0102
Issued by

View the file

Other files

File Type Posted
SUMMARY OF CHANGES - Kay County CBOC 02.docx DOCX document
36C25922R0102 0005.docx DOCX document
36C25922R0102 v3.docx DOCX document
Kay County CBOC Questions and Response Follow up.docx DOCX document
36C25922R0102 0004.docx DOCX document
D.14 OUTPATIENT CLINIC MANAGEMENT.pdf PDF
36C25922R0102 0003.docx DOCX document
D.9 REPORTING ADVERSE DRUG EVENTS2.pdf PDF
Kay County CBOC Questions and Response.docx DOCX document
36C25922R0102 v2.docx DOCX document
D.23 MANAGEMENT OF BREAST CANCER SCREENING2.pdf PDF
D.22 EQM MEASURE LIST.pdf PDF
D.1 ANTICOAGULATION MANAGEMENT PROGRAM2.pdf PDF
D.18 ANCILLARY TESTING POLICY2.pdf PDF
D.15 CONSULT PROCESSES AND PROCEDURES.pdf PDF
D.32 DBA OK20230068 02102023.pdf PDF
D.10 RIGHTS AND RESPONSIBILITIES OF PATIENTS2.pdf PDF
D.31 PAST PERFORMANCE QUESTIONNAIRE2.pdf PDF
D.24 OUTPATIENT SCHEDULING MANAGEMENT.pdf PDF
D.2 1345 MEDICATION RECONCILLATION.pdf PDF
SUMMARY OF CHANGES - Kay County CBOC.docx DOCX document
D.6 ORDERING AND REPORTING TEST RESULT2.pdf PDF
D.5 HEALTHCARE PROVIDER MEDICAL RECORDS DELINIQUENCIES2.pdf PDF
D.16 CERVICAL CANCER SCREENING2.pdf PDF
36C25922R0102 0002.docx DOCX document
36C25922R0102 0001.docx DOCX document
D.13 TELEPHONE SERVICE FOR CLINICAL CARE.pdf PDF
D.17 CONTRACTOR SECURITY REQUIREMENTS (HANDBOOK 6500.6).pdf PDF
D.27 VHA HOME TELEHEALTH OPERATIONS.pdf PDF
D.18 ANCILLARY TESTING POLICY.pdf PDF
D.1 ANTICOAGULATION MANAGEMENT PROGRAM (1).pdf PDF
D.25 VHA CLINIC BASED TELEHEALTH OPERATIONS 1.pdf PDF
D.2 CM 11-135 MEDICATION RECONCILIATION PROCESS.pdf PDF
D.35 ORG CONFLICT OF INTEREST.pdf PDF
D.37 SMALL BUSINESS SUBCONTRACTING PLAN CERTIFICATION.pdf PDF
D.26 VHA CLINIC BASED TELEHEALTH OPERATIONS 2.pdf PDF
D.12 SERVICE CONTRACT ACT OF 1965, AS AMENDED.pdf PDF
D.10 RIGHTS AND RESPONSIBILITIES OF PATIENTS.pdf PDF
D.29 SCA 15-5323 WAGE DETERMINATION.pdf PDF
D.19 DOCUMENT SCANNING POLICY.pdf PDF
D.33 LABORTORY MANUAL.pdf PDF
D.6 ORDERING AND RESPORTING TEST RESULTS.pdf PDF
D.20 LAB SUPPLIES.pdf PDF
D.3 GSA SECURITY GUIDE.pdf PDF
D.24 OUTPATIENT SCHEDULING PROCESSES AND PROCEDURES.pdf PDF
D14. USE OF RADIATION GENERATING EQUIPMENT.pdf PDF
D.15 USE OF UNLICENSED ASSISTIVE PERSONNEL IN ADMINISTERING MEDICATION .pdf PDF
D.31 PAST PERFORMANCE QUESTIONAIRE.pdf PDF
D.38 VALIDATED PERIPHERAL LIST - PRINTERS AND SCANNERS.pdf PDF
D.4 HEALTH INFORMATION MANAGEMENT.pdf PDF
Show 40 more

Latest 50 of 64 listed here. See the rest on GovTribe.

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

D.22 EQM MEASURES

36C25922R0102

Available Measures by Reporting Period Displays all available measures and the associated years for which data is available.

Measures Available FY17 FY18 FY19 FY20 FY21 c9h_ec DM - Outpt - HbA1c Annual ( eMeasure ) dmg10h_ec Outpatient HbA1c less than 8 ( eMeasure ) dmg11h_ec Outpt HbA1c less than 7 ( eMeasure ) dmg12h_ec Outpatient HbA1c less than 8 ( eMeasure ) dmg13h_ec Outpatient HbA1c less than 8 ( eMeasure ) dmg23h_ec DM: HbA1c poor control ( eMeasure ) dmg27h_ec DM: BP LT 140/90 ( eMeasure ) dmg34h_ec DM: Medical attention for nephropathy - Renal Testing (OP)(eMeasure) dms40_ec PHQ-9 Utilization ( eMeasure ) dms40a_ec PHQ-9 Utilization Rate (ages 18-44) ( eMeasure ) dms40b_ec PHQ-9 Utilization Rate (ages 45-64) ( eMeasure ) dms40c_ec PHQ-9 Utilization Rate (ages 65+) ( eMeasure ) ed1_ec Admitted Pts Median Time ED arriv to ED depart-overall ( eMeasure ) ed5_ec Decision to Admit time to ED depart- overall fuh30_ec fuh30_ec ihd51h_ec HTN: Outpatient BP less than 140/90 age 60-85 and dx DM (OP) ( eMeasure ) ihd52h_ec HTN: Outpatient BP less than 150/90 age 60-85 and no DM ( eMeasure ) ihd53h_ec Controlling High Blood Pressure ( eMeasure ) ihd5h_ec HTN: Outpatient BP less than 140/90 age 18-59 ( eMeasure ) mdd43h_ec Effective Acute Phase Treatment (12 weeks) ( eMeasure ) mdd47h_ec Effective Continuation Phase Treatment (6 months) ( eMeasure ) p28h_ec Influenza Immunizations 66 years of age and older (eMeasure) p29h_ec Influenza Immunization 19-65 years of age (eMeasure) psa1_ec Non-Recommended PSA-Based Screening ( eMeasure ) scid3_ec DM - HbA1c GT 9 or not done in past year (SCI&D) (eMeasure) scid4_ec DM - BP LT 140/90 (SCI&D)(eMeasure)

D.22 EQM MEASURES

36C25922R0102 scid7_ec DM - BP GE 160/100 or not done (SCI&D) ( eMeasure ) statn1_ec Statin Therapy for patients with cardiovascular disease ( eMeasure ) statn2_ec Statin therapy for patients with cardiovascular disease: men ( eMeasure ) statn3_ec Statin therapy for patients with cardiovascular disease: women ( eMeasure ) statn4_ec Statin adherence for patients with cardiovascular disease ( eMeasure ) statn5_ec Statin adherence for patients with cardiovascular disease: men ( eMeasure ) statn6_ec Statin adherence for patients with cardiovascular disease: women ( eMeasure ) statn7_ec Statin therapy for patients with diabetes ( eMeasure ) statn8_ec Statin adherence for patients with diabetes ( eMeasure ) stk2_ec Discharged on Antithrombotic Therapy ( eMeasure ) stk6_ec Discharged on Statin Medication ( eMeasure ) vte1_ec Venous Thromboembolism Prophylaxis - All (eMeasure) vte2_ec VTE Prophylaxis - ICU ( eMeasure )

File details come from the government source that posted it. Updated .